Rapt Therapeutics Inc (RAPT) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access RAPT Annual Balance Sheets →
A period-by-period view of the balance sheet from Rapt Therapeutics Inc to Sep 30 2024 helps clarify how Sep 30 2025's financial structure has changed over time.
Quarterly Report, GAAP in USD millions
ITEM
(Sep 30 2025)
(Jun 30 2025) (Mar 31 2025) (Dec 31 2024) (Sep 30 2024)
Assets
Cash & cash equivalent37.93
Marketable Securities, Current SH119.41
Cash & Short-term Investments156.00
Prepaid Expense And Other Assets Current3.70
Total Current Assets161.05
Equipment/Property/Plant Net0.77
Other Assets, Noncurrent3.00
Operating Lease Right Of Use Asset1.88
Total Assets165.74
Liabilities
Accounts Payable, Current AC2.10
Accrued Liabilities, Current AC9.01
Other Liabilities, Current2.27
Total Current Liabilities13.38
Total Long-term Debt0.00
Other liabilities, Noncurrent0.39
OperatingLeaseLiabilityNoncurrent0.39
Operating Lease Liability Current2.21
Total Liabilities13.76
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock818.81
Retained Earnings / Accumulated Deficit-666.94
Other Equity0.10
Common Stockholder's Equity151.98
Total Stockholder's Equity151.98
Liabilities & Stockholder's Equity165.74
4 historic quarters locked

Sign in to unlock the full Rapt Therapeutics Inc balance sheet history.

About Rapt Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-25-268141

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.